Intelligent Health Intelligent Health 2024 | 11–12 September | Europe

The world’s leading AI in medicine summit series

It’s about more than just health: it’s Intelligent Health

 

11-12 September 2024
Congress Center Basel
Basel, Switzerland

Meet your peers at the forefont of change

Book your tickets for 2024

Newsletter

Partner with us

 

Connecting 260,000 clinicians, technologists and C-suite executives to create a future where AI will revolutionise health

Produced by

IT’S ABOUT MORE THAN JUST HEALTH.
IT’S INTELLIGENT HEALTH.

Intelligent Health hosts the world’s largest healthtech community dedicated to saving lives with AI. CPD accredited and aligned with the UN Sustainable Development Goals, we are committed to advancing pivotal conversations on AI in medicine and fostering global collaboration across the healthcare sector.

Our comprehensive agenda offers access to leading expert voices; expediting critical discussions on the latest challenges, solutions and innovations to facilitate key decision-making and help you make investments that matter.

2024 programme will cater to senior decision makers

To ensure Intelligent Health offers the highest degree of relevance to our audience, our new 2024 programme will cater to senior decision makers, offering application-only places. This exclusive format will allow you to connect with senior representatives from leading organisations in AI and healthcare offering premium insights, through exceptional networking, business meetings, and strategic “big picture” sessions.

If you are a senior stakeholder in AI in healthcare, we invite you to confirm your attendance where you will be united with fellow decision makers and budget holders to drive meaningful change in the industry.

Our mission is to ensure the safe, effective and democratic adoption of AI in healthcare to improve global health outcomes for all.

“The Intelligent Health event is an invaluable platform for bridging the gap between tech experts and healthcare practitioners, fostering meaningful dialogue. I highly value the in-depth conversations and insights gained from innovators and change makers at the event. Healthcare needs AI, because it needs the human touch."

Senior Director Digital Ecosystem EMEA

GE HealthCare

"Unlike any I've attended before - It was a unique combination of science and glamour - all presented in a format that kept my full attention."

Co-Founder and Chief Science Officer

Lapetus

"A pioneering event that gets health care providers, hospitals, data scientists, startups & corporates together to talk about challenges and disruptive changes and how to get them realised. Great energy and great insights."

Consultant Cardiac Anaesthetist, AMC & Founder

Healthplus.ai

Connect

Be part of the Intelligent Health community and meet like-minded professionals who create positive changes by using AI in the healthcare industry.

 

 

Companies attending

Engage

We bring together the full AI healthcare ecosystem to learn and drive the changes that will really make an impact to the future of humanity. Raise your company’s profile and position yourself in front of the brightest AI healthcare brains

 

 

Partner with us

Learn

With a Headline Plenary Stage featuring some of the leading global voices in the Healthcare and AI sector, and supporting tracks featuring AI in action use cases from innovative clinicians, deep dive tech talks, innovation insights, workshops and roundtables from the hottest researchers, academics and tech companies, the two-day programme addresses all the key opportunities and challenges faced by the industry today.

 

Content and programme

Who you will meet

  • Hospitals, Health Practices, Big Tech, Health Tech AI, Startups, Pharma, Biotech and Medical Device, Health insurers, Academics, Investors, Associations
  • CEO, CTO, CMIO, CCIO, CIO, CDIO, CMO, CDO, CSO, Directorate Digital Lead​​
  • VP, Director, Head of, Managing Director, Head of Technology/Innovation/ AI/ Machine Learning/ Computer Vision/ Cognitive Computing/Data Science/ Data Analytics/ Data Strategy
  • Clinicians and healthcare professionals:
  • Heads of, Directors, Consultants in Oncology, Radiology, Pathology, Medicinal Chemistry, Cell Therapy, Rare diseases, Biosimilars, Imaging, Diabetes, Opthalmology, Cardiology, Diagnostics

 

 

 

What’s on at Intelligent Health 2024

  • Plenary sessions: live with mind-blowing speakers and world leaders. Our speakers are a true inspiration and are shaping the AI health tech revolution.
  • NEW: Roundtable discussions: small focus groups examining how to solve some of the key challenges currently facing the industry. Honest, open and senior-level discussions with your peers.
  • AI in action use cases: real-life practical use cases from the top AI brains in healthcare and technology, examining how AI has the potential to transform care delivery and life science research.
  • Deep dive tech talks: the world’s leading tech innovators across healthcare, tech and academia on fundamental breakthroughs using AI which will change lives and reshape healthcare
  • Innovation insights: editorial picks of the agile technologists who are innovating at pace and creating entirely new models for AI application.
  • Workshops: led by experts, these workshops offer a chance for you to work through various topical issues and solutions and will leave you with top tips to take away to implement into your own workflow.
  • Curated 1-2-1 meetings: using our AI-powered matchmaking tool – physically, there will be managed meeting points.

Meet our industry pioneers –

all of our past AI in medicine Brains

 

DR ANN AERTS
Head of Novartis Foundation
Novartis Foundation
 
DR ANN AERTS
Head of Novartis Foundation
Novartis Foundation
 
DR. ERIC TOPOL
Executive Vice-President | Scripps Research Institute
Director & Founder | Scripps Research Translational Institute
DR. ERIC TOPOL
Executive Vice-President | Scripps Research Institute
Director & Founder | Scripps Research Translational Institute

Eric Topol is the Founder and Director of the Scripps Research Translational Institute, Professor, Molecular Medicine, and Executive Vice-President of Scripps Research. As a researcher, he has published over 1,200 peer-reviewed articles, with more than 310,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine. His principal scientific focus has been on the genomic and digital tools to individualize medicine.

In 2016, Topol was awarded a $207 million grant from the NIH to lead a significant part of the Precision Medicine (All of Us) Initiative, a prospective research program enrolling 1 million participants in the US. This is in addition to his role as principal investigator for a flagship $35M NIH grant to promote innovation in medicine. He was the founder of a new medical school at Cleveland Clinic, Lerner College of Medicine, with Case Western University. He has over 440,000 followers on Twitter (@EricTopol) where recently he has been reporting insights and research findings for COVID-19. Besides editing several textbooks, he has published 3 bestseller books on the future of medicine: The Creative Destruction of Medicine, The Patient Will See You Now, and Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again. Lastly, Topol was commissioned by the UK 2018-2019 to lead planning for the National Health Service’s integration of AI and new technologies.

Laura Matz
Chief Science & Technology Officer
Merck KGaA
Laura Matz
Chief Science & Technology Officer
Merck KGaA

Dr. Laura Matz serves as the Chief Science and Technology Officer at Merck KGaA Darmstadt, Germany, a role that entails spearheading the innovation agenda of a distinguished science and technology enterprise with a heritage exceeding 350 years in chemistry, biotechnology, and integrated materials solutions. In her capacity, Laura collaborates closely with the Company Board and partners with Innovation Heads across Merck KGaA’s three leading industry verticals: Life Science, Healthcare, and Electronics. Her visionary leadership is instrumental in shaping the future of the enterprise, leveraging digital and AI/ML technologies to drive innovation, exploring new markets, fostering strategic partnerships, and developing cutting-edge capabilities and digital business models to deliver groundbreaking solutions. A recent notable achievement includes her role as CEO in launching Athinia™, a joint venture with Palantir, which introduced a pioneering data collaboration platform for the semiconductor ecosystem. Prior to assuming the role of CSTO, Laura held the position of Senior Vice President within EMD Electronics, previously Versum Materials and Air Products Electronics division. With over 20 years, of experience in semiconductor manufacturing and a decade dedicated to running semiconductor materials businesses, she has been driving force the advancements in the field, prioritizing robust R&D for business expansion. Beyond her role at Merck KGaA, Laura serves on the Board of Directors of transformative organizations. She’s a board member of AIChE (American Institute of Chemical Engineers) and of SEMI. Laura also serves as Director on the board of AION Labs.

DR. GREG MOORE
CVP
Microsoft Health & Life Sciences
             
DR. GREG MOORE
CVP
Microsoft Health & Life Sciences
             

Dr. Moore leads Microsoft’s Health efforts globally and is responsible for product strategy, product development, and research including AI and machine learning technology for healthcare and life sciences. He is also Microsoft’s senior executive leading dedicated research and development collaborations with Microsoft’s strategic alliance partners in this domain with the goal of enabling a more open, interoperable, and AI-infused foundation for healthcare delivery that aspires to enable access to healthcare for all globally.

Greg is an engineer (MIT PhD), practicing neuroradiologist, clinical informaticist, neuroscientist, and innovator experienced in assembling and inspiring highly talented teams to positively transform healthcare for the benefit of humankind. Prior to joining Microsoft, Greg was Vice President Google Inc, Google Cloud Healthcare & Life Sciences and founder of the healthcare vertical for Google Cloud. Prior to his leadership appointment at Google, he was Chief Emerging Technology and Informatics Officer at Geisinger Health System where he also was Director of the Institute for Advanced Application and served as Interim Chair of System Radiology. His prior appointments include Los Alamos National Laboratory (University of California), Wayne State University School of Medicine, Children’s Hospital of Michigan and Penn State University Hershey Medical Center where he was a tenured Professor in the College of Medicine. Greg currently serves on the board Hillrom Inc, and is an Adjunct Clinical Professor of Radiology at Stanford University School of Medicine.

Moore is board certified in Diagnostic Radiology, Neuroradiology and Clinical Informatics and holds degrees from North Park College-Chicago (BS), Massachusetts Institute of Technology (SM-Nuclear Engineering and PhD-Radiological Sciences), and Wayne State University School of Medicine (MD-Doctor of Medicine) and completed residency in Diagnostic Radiology and a fellowship in Neuroradiology, both at Penn State University Hershey Medical Center.

CAROLYN STARRETT
CEO
Flatiron Health
CAROLYN STARRETT
CEO
Flatiron Health

Carolyn Starrett is CEO of Flatiron Health®, a world leader in transforming patients’ real-life experiences into knowledge to help accelerate improvements in cancer care and treatments.

Almost everything known today about what works for patients with cancer comes from the relative few who enroll in randomized controlled trials. Flatiron uses clinical and data science to improve lives by learning from the experience of every cancer patient. Insights from Flatiron’s U.S-derived real-world data and analyses support meaningful learnings relevant to a global cancer population, and have helped expand treatment alternatives for people with gastric, colorectal, esophageal, breast, and head and neck cancer. Through three international subsidiaries, Flatiron now also works to improve treatments and outcomes for cancer patients in Japan, Germany and the United Kingdom.

Carolyn became Flatiron CEO in April, succeeding the company’s co-founders and bringing a deep understanding of the challenges facing those on the cancer frontlines from her years leading the company’s community oncology business. Prior to joining Flatiron in 2016, Carolyn held senior strategy, product and operations roles at data and technology companies, and worked with healthcare and technology companies as a principal with Boston Consulting Group. Carolyn holds an MBA from the Kellogg School of Management at Northwestern University and a Bachelor’s degree from Brown University.

MONA FLORES
Global Head of Medical AI
Nvidia
MONA FLORES
Global Head of Medical AI
Nvidia

Mona is the Global Head of Medical AI at NVIDIA. She brings a unique perspective with her varied experience in clinical medicine, medical applications, and business. She is a board-certified cardiac surgeon and the previous Chief Medical Officer of a digital health company. She holds an MBA in Management Information Systems, and has worked on Wall Street. Her ultimate goal is the betterment of medicine through AI.

Sunil Dadlani 
EVP, Chief Information & Digital Officer & Chief Cyber Security Officer
Atlantic Health System
Sunil Dadlani 
EVP, Chief Information & Digital Officer & Chief Cyber Security Officer
Atlantic Health System

Sunil Dadlani is an accomplished global business technology leader who has spent his extensive career in this sector using his expertise to develop and implement complex, global information technology strategies and processes. 

He joined Atlantic Health System in September 2020 and oversees Information Technology systemwide. In this role, Mr. Dadlani continues to advance the system’s use of information technology strategies and platforms to help support the delivery of excellent patient care and team member experiences. One particular focus is the management and continued growth and development of the system’s electronic medical record, Epic.

Prior to joining Atlantic Health System, Mr. Dadlani was the Chief Information Officer for the New York State Department of Health. He successfully led the largest public-sector digital business technology transformation, delivering digital health care services to 19 million New Yorkers.

Prior to this, Mr. Dadlani served as the Global Head of Enterprise Business Applications & Digital Transformation at Sony.

Mr. Dadlani earned his MBA in Global Management and a Masters in Computer Science and Information Systems. He is an advisory board member for the NY Health Information Technology (HIT) and Health Information Exchange (HIE).

PROFESSOR SIR NIGEL SHADBOLT
Professor of Computing Science | University of Oxford
Chairman and Co-Founder | Open Data Institute
PROFESSOR SIR NIGEL SHADBOLT
Professor of Computing Science | University of Oxford
Chairman and Co-Founder | Open Data Institute

Sir Nigel Shadbolt is Principal of Jesus College and Professor of Computing Science at the University of Oxford, where he has centred his research in human centred AI in a wide range of applications.  Most recently he was asked to lead the setting up of the Oxford Institute of Ethics in AI.  He is also the Chairman and Co-Founder of the Open Data Institute (ODI).  Since 2009, Sir Nigel has helped transform public access to Government information.

In 2010, he joined the UK government’s Public Sector Transparency Board – overseeing Open Data releases across the public sector.  He was knighted in 2013 for ‘services to science and engineering’. 

With over 500 publications, he has researched and published on topics ranging from cognitive psychology to computational neuroscience, Artificial Intelligence to the Semantic Web.  In 2018 he published The Digital Ape: how to live (in peace) with smart machines, described as a ‘landmark book’.

He is a Fellow of The Royal Society, the Royal Academy of Engineering and the British Computer Society.

DR. JUNAID BAJWA
Chief Medical Scientist
Microsoft
DR. JUNAID BAJWA
Chief Medical Scientist
Microsoft

Dr. Junaid is a practicing physician in the NHS and is also the Chief Medical Scientist at Microsoft Research. He also serves as a Non-Executive Director at University College London Hospitals NHS Foundation Trust. He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme (Merck & Co), where he helped shape their global digital strategy. Junaid also has experience in the academic world where he is a Clinical Associate Professor at University College London (UCL), and a Visiting Scientist at the Harvard School of Public Health. Over the past 15 years, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer,and policy maker within the UK, where he specialised in informatics, digital transformation, and leadership. He has also acted as a consultant for health care systems across the US, Australia, New Zealand, Singapore, the Middle East, and Europe.

ROLAND ROTT
President & CEO Ultrasound
 GE HealthCare
ROLAND ROTT
President & CEO Ultrasound
 GE HealthCare

Roland Rott is President & CEO of GE HealthCare Ultrasound & Cardiology, a global leader that has defined ultrasound innovation for over 25 years. In this role, Roland is responsible for driving the growth and innovation of the ~$3 billion business with more than 3000 employees worldwide. In his tenure leading the Ultrasound & Cardiology segment he has presided over the acquisition of surgical visualization & guidance pioneer BK Medical, the company’s largest acquisition since 2017, the equity investment in at-home ultrasound start-up Pulsenmore and the acquisition of AI healthcare leader Caption Health. Since joining GE HealthCare, Roland has held senior roles Ultrasound IT and Women’s Health, and prior to his appointment as President & CEO of Ultrasound, served as General Manager of Women’s Health Ultrasound, where he grew the strategic business unit to become the market leader in obstetrics/gynecology worldwide. Before joining GE HealthCare, Roland was Managing Director, Europe, Middle East & Africa (EMEA) and executive board member at Exact Software— a mid-cap public company headquartered in the Netherlands— leading four R&D teams and subsidiaries in 20 countries. Early in his career Roland was an entrepreneur who founded two successful software companies in Austria that were later acquired by strategic investors. Roland earned his post-secondary diploma (HTL) in Engineering with specialization in Information Technology & Business Administration from HTBLA Leonding in Austria, studied International Business Administration at Leopold-Franzens Universität Innsbruck, and has completed executive education programs at Stanford University, London Business School, and the University of California at Berkley. He lives in Vienna, Austria with his wife and three children.

PROF. DR. EFFY VAYENA
Professor
Institute of Translational Medicine
PROF. DR. EFFY VAYENA
Professor
Institute of Translational Medicine
DR OLIVER MORGAN
Director of Health Emergency and Risk Assessment - WHO Health Emergencies Program
World Health Organization
DR OLIVER MORGAN
Director of Health Emergency and Risk Assessment - WHO Health Emergencies Program
World Health Organization

Dr. Oliver Morgan is the Director of the Health Emergency Information and Risk Assessment Department in the WHO Health Emergencies Program.  From 2007 through 2016, Dr. Morgan worked for the US Centers for Disease Control and Prevention during which time he held critical leadership positions in the Ebola response between November 2014 and February 2016 (CDC Atlanta Ebola Response Incident Manger and CDC Country Director in Sierra Leone). From March 2010 to October 2014, Dr. Morgan was the CDC Country Director in the Dominican Republic.  Dr. Morgan was an Epidemic Intelligence Service Officer at CDC from 2007 to 2009 with the International Emerging Infections Program, during which time he conducted projects in Thailand, Bangladesh, Kenya, Uganda, and Guatemala.  

Before joining CDC, Dr. Morgan worked for the UK Health Protection Agency, leading epidemiological investigations of outbreaks (enteric, vaccine preventable, hospital acquired, zoonotic, respiratory, and sexually acquired infections), chemical and radiation exposure incidents, terrorist bombings in London, natural disasters, and humanitarian civil conflicts.  Dr. Morgan has also worked as a consultant to WHO/PAHO in several countries.  Dr. Morgan’s academic achievements include a doctorate in epidemiology from Imperial College London and extensive publication in peer reviewed journals and reference books.

Our Intelligent Health AI global summit series

 

11 – 12 September 2024 

Basel, Switzerland

Intelligent Health AI will once again bring together the global AI and health community next September to advance discussions on how AI can be used to prevent and solve some of the world’s greatest healthcare problems, and improve the health of the human race to #SaveLivesWithAI.

Learn more

intelligenthealth.ai

10 – 11 December 2024 

Doha, Qatar

Intelligent Health is known for its unwavering commitment to fostering diversity and equality. We firmly believe in the democratization of AI in healthcare, striving to make the transformative power of artificial intelligence accessible to all regions and communities, contributing to the collective advancement of AI on a global scale.

HELD UNDER THE OFFICIAL PATRONAGE OF MINISTRY OF COMMUNICATIONS AND INFORMATION TECHNOLOGY, STATE OF QATAR

Learn more

qatar.worldsummit.ai/intelligent-health-qatar/

TBC 2025

London, United Kingdom

Intelligent Health UK will return to London and bring together again the global AI and healthcare community – clinicians, hospital heads, data scientists, startups, academics, and investors – to advance discussions on how to apply AI and drive technological collaboration in healthcare.

Learn more

london.intelligenthealth.ai

Thank you to our supporters!